Jill E. Sackman, PhD

The Australian pharmaceutical market offers opportunities for manufacturers despite challenges.

Investors are lining up for the biosimilars market as patents reach expiration and regulatory pathways are defined.

The authors take a look at some of the recent developments in the German pharmaceutical market.

Data analytic strategies can help companies capitalize on personalized medicine.

Biopharma companies should not overlook India's growing market.

The biopharmaceutical industry contemplates product innovation within the changing landscape of healthcare.

Israel's diverse population, high-quality healthcare system, and resilience to global financial stress make it a strong partner for R'D, clinical research, and market growth.

The pharmaceutical industry grows despite conflict in the Middle East.

The bio-pharmaceutical business outlook in South Korea remains positive

A unique demographic and payer mix make ASEAN an increasingly attractive region.

Latin America's diverse growing market seeks regulatory harmonization.

Eastern Europe is moving towards a goal of harmonized regulations.

An introduction to a new series on manufacturing within global markets.

The industry must be prepared for the impact of the sweeping changes expected from the new legislation.